This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Molina Healthcare (MOH) Gets a Hold from Goldman Sachs

Tipranks - Tipranks - Tue Apr 28, 8:44AM CDT

Goldman Sachs analyst Scott Fidel maintained a Hold rating on Molina Healthcare today and set a price target of $124.00.

Claim 55% Off TipRanks

According to TipRanks, Fidel is a 4-star analyst with an average return of 8.7% and a 63.46% success rate. Fidel covers the Healthcare sector, focusing on stocks such as Molina Healthcare, Centene, and UnitedHealth.

In addition to Goldman Sachs, Molina Healthcare also received a Hold from Truist Financial’s David S Macdonald in a report issued today. However, on April 24, Barclays maintained a Sell rating on Molina Healthcare (NYSE: MOH).

See the top stocks recommended by analysts >>

Based on Molina Healthcare’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $10.8 billion and a net profit of $14 million. In comparison, last year the company earned a revenue of $11.15 billion and had a net profit of $298 million

Based on the recent corporate insider activity of 60 insiders, corporate insider sentiment is neutral on the stock. Last month, Ronna Romney, a Director at MOH sold 506.00 shares for a total of $74,341.52.

Read More on MOH:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).